首页 > 市场调查报告书 > 製药

处方药

市场调查报告书

商品编码

1796521

全球克隆氏症药物市场报告：趋势、预测和竞争分析（至 2031 年）

Crohn's Disease Treatment Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日期: 2025年08月22日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录图表

全球克隆氏症药物市场前景光明，小肠和大肠市场都蕴藏着机会。预计2025年至2031年期间，全球克隆氏症药物市场规模将以3.8%的复合年增长率成长。该市场的主要驱动力包括：全球克隆氏症的上升、治疗需求的增加、持续的药物研发以带来更有效的治疗方案，以及认知度和诊断水平的提高，从而促进治疗方案的采用。

Lucintel 预测，由于免疫调节药物具有针对性的作用和日益普及的采用率，预计在预测期内，免疫调节药物将实现高速成长。
在应用方面，小肠预计将出现最高的增长，因为它是克隆氏症最常影响的区域。
按地区划分，北美预计将在预测期内实现最高成长，因为它拥有强大的医疗保健基础设施和认知度。

克隆氏症治疗市场的新趋势

生物疗法、精准医疗和新治疗方案等新兴趋势正在改变克隆氏症药物市场，改善患者预后、优化治疗并扩大治疗机会。

生物製药：抗肿瘤坏死因子抑制剂、抗整合素疗法和白细胞介素抑制剂是治疗中度至重度克隆氏症的快速成长的药物。生物製药比传统药物更具特异性和效力，副作用较少，疾病控制效果较好。生物製药也正在推动市场成长。
口服药物：克隆氏症口服治疗的引入，透过提供更方便的选择，正在彻底改变患者的治疗方案。 JAK抑制剂等口服药物减少了注射需求，并提高了患者的依从性和生活品质。这一趋势可望推动市场成长，尤其是在寻求更容易管理治疗方法的患者群体中。
个人化医疗：精准医疗是一种新兴趋势，它根据患者的基因图谱和疾病特征量身订做治疗方案。识别特定的生物标记物使医生能够个性化克隆氏症的治疗，从而改善疗效并减少副作用。这种方法可能会对克隆氏症的治疗方法产生重大影响。
生物相似药：随着生物製药应用的不断扩大，生物相似药的开发已成为治疗克隆氏症的一种经济有效的解决方案。生物相似药是品牌生物製药的替代品，价格更实惠，有望改善患者获得优质医疗服务的管道，尤其是在医疗预算有限的新兴市场。
远端医疗和远端监控：远端医疗和远端患者监护在克隆氏症治疗市场中日益普及。这些技术使医疗保健提供者能够远端追踪患者的症状和治疗依从性，从而改善疾病管理。远端医疗可以实现更好的后续护理，并及时调整治疗方法，从而改善患者的治疗效果。

生物製药、口服药物、个人化医疗、生物相似药和远端医疗等新兴趋势正在颠覆克隆氏症药物市场。这些创新正在丰富治疗选择，改善患者预后，扩大医疗服务可近性，并重塑全球克隆氏症的治疗模式。

克隆氏症病药物市场的最新发展

克隆氏症治疗市场近期呈现显着趋势，这主要得益于生物製药、口服药物和诊断技术的创新。这些发展有助于提高疾病管理的有效性，并为患者和製药公司创造重大机会。

新型生物製药核准：多种新型生物製药已核准用于治疗克隆氏症，为中度至重度克隆氏症症患者提供更有针对性、更有效的治疗。这些药物针对特定的发炎通路，与传统治疗方法相比，可更好地控制病情并减少副作用。
口服JAK抑制剂的推出：口服Janus抑制剂（用于治疗克隆氏症）的核准和上市，改变了治疗格局。这些口服药物为注射用生物製药提供了替代方案，使患者的治疗更轻鬆便捷，从而提高了依从性和整体治疗效果。
生物相似药与成本降低：生物相似药的发展使生物製药治疗更经济实惠，患者也更容易取得。生物相似药的推出有助于克隆氏症治疗市场的扩张，因为它减轻了患者成本负担，使更多患者能够从生物製药中受益。
先进的诊断工具：生物标记和先进的影像技术等新型诊断工具正在改善克隆氏症的诊断和监测。这些进步使得更早发现疾病并更准确地监测其进展成为可能，从而改善疗效并实现个人化治疗。
关注个人化医疗：个人化医疗是指根据个别基因组成和疾病特征制定个人化治疗方案，在克隆氏症的治疗中日益受到重视。利用基因检测来确定治疗方案，有可能改善疗效并减少副作用。

克隆氏症治疗市场的最新发展，包括新型生物製药、口服JAK抑制剂、生物相似药、先进诊断技术和个人化医疗，正在重塑治疗格局。这些创新正在改善患者照护，并为克隆氏症的治疗提供更有针对性、更便捷、更具成本效益的选择。

The future of the global Crohn's disease treatment drug market looks promising with opportunities in the small intestine and large intestine markets. The global Crohn's disease treatment drug market is expected to grow with a CAGR of 3.8% from 2025 to 2031. The major drivers for this market are the rising prevalence of Crohn's disease globally, which increases demand for treatment, advancements in drug development that lead to more effective therapies, and increased awareness and diagnosis that drive higher adoption of treatment options.

Lucintel forecasts that, within the type category, immunomodulators are expected to witness higher growth over the forecast period due to their targeted action and increasing adoption.
Within the application category, the small intestine is expected to witness the highest growth due to more frequent involvement in Crohn's disease.
In terms of region, North America is expected to witness the highest growth over the forecast period due to advanced healthcare infrastructure and awareness.

Emerging Trends in the Crohn's Disease Treatment Drug Market

Emerging trends such as biologic therapies, precision medicine, and new treatment options are changing the Crohn's disease treatment drug market. These emerging trends are shaping the market in terms of improving patient outcomes, optimizing treatments, and expanding access to medications.

Biologics: Anti-TNF inhibitors, anti-integrin therapies, and interleukin inhibitors are a fast-growing treatment avenue for moderate to severe Crohn's disease. Biologics are more specific and more potent than conventional drugs; thus, they help patients with fewer side effects and improved disease control. Biologic drugs have also driven the growth of the market.
Oral Medications: The introduction of oral treatments for Crohn's disease is revolutionizing patient care by offering more convenient options. Drugs like JAK inhibitors, which can be taken orally, reduce the need for injections, improving patient compliance and quality of life. This trend is likely to drive market growth, especially among patients seeking more manageable treatment regimens.
Personalized Medicine: Precision medicine is an emerging trend that tailors treatments based on a patient's genetic profile and disease characteristics. By identifying specific biomarkers, doctors can personalize treatments for Crohn's disease, leading to better outcomes and fewer side effects. This approach has the potential to significantly impact treatment regimens for Crohn's disease.
Biosimilars: With the growing use of biologics, the development of biosimilars has emerged as a cost-effective solution for managing Crohn's disease. These alternatives to branded biologics are more affordable and are expected to improve access to high-quality treatments for patients, particularly in emerging markets with limited healthcare budgets.
Telemedicine and Remote Monitoring: Telemedicine and remote patient monitoring are gaining traction in the Crohn's disease treatment market. These technologies enable healthcare providers to track patient symptoms and treatment adherence from a distance, improving the management of the disease. Telemedicine allows for better follow-up care and timely adjustments to treatment regimens, enhancing patient outcomes.

Emerging trends such as biologic therapies, oral medications, personalized medicine, biosimilars, and telemedicine are driving significant changes in the Crohn's disease treatment drug market. These innovations are enhancing treatment options, improving patient outcomes, and expanding access to care, reshaping how Crohn's disease is managed globally.

Recent Developments in the Crohn's Disease Treatment Drug Market

The Crohn's disease treatment drug market has seen notable developments in recent years, driven by innovations in biologics, oral therapies, and diagnostic techniques. These developments have contributed to more effective disease management and offer significant opportunities for both patients and pharmaceutical companies.

Approval of New Biologic Therapies: Several new biologic drugs have been approved for Crohn's disease, offering more targeted and effective treatments for patients with moderate-to-severe disease. These drugs work by targeting specific inflammatory pathways, resulting in better disease control and fewer side effects compared to traditional therapies.
Introduction of Oral JAK Inhibitors: The approval and introduction of oral Janus kinase (JAK) inhibitors for Crohn's disease have been a game-changer in the treatment landscape. These oral medications offer an alternative to injectable biologics, making treatment easier and more convenient for patients, thus improving adherence and overall treatment outcomes.
Biosimilars and Cost Reduction: The development of biosimilars has made biologic treatments more affordable, leading to greater accessibility for patients. The introduction of biosimilars is helping to expand the market for Crohn's disease treatments by reducing the cost burden and allowing more patients to benefit from biologic therapies.
Advanced Diagnostic Tools: New diagnostic tools, such as biomarkers and advanced imaging techniques, are improving the diagnosis and monitoring of Crohn's disease. These advancements allow for earlier detection and more accurate monitoring of disease progression, leading to better treatment outcomes and personalized care.
Focus on Personalized Medicine: Personalized medicine, which tailors treatments to an individual's genetic makeup and disease profile, is gaining momentum in the management of Crohn's disease. The use of genetic testing to guide treatment decisions is expected to improve therapeutic outcomes and reduce side effects, as therapies are better matched to the patient's specific needs.

The recent developments in the Crohn's disease treatment drug market, including new biologic therapies, oral JAK inhibitors, biosimilars, advanced diagnostics, and personalized medicine, are reshaping the treatment landscape. These innovations are improving patient care and offering more targeted, convenient, and cost-effective options for managing Crohn's disease.

Strategic Growth Opportunities in the Crohn's Disease Treatment Drug Market

The Crohn's disease treatment drug market presents several strategic growth opportunities, particularly through innovations in biologic therapies, oral medications, and emerging markets. Pharmaceutical companies are looking to expand their portfolios and reach new patient populations by addressing unmet medical needs in Crohn's disease treatment.

Expansion of Biologic Therapies: As biologic therapies continue to show strong efficacy in treating Crohn's disease, there is significant growth potential in developing and marketing new biologics. Companies can capitalize on this opportunity by exploring new targets in immune pathways to develop next-generation therapies that provide even better outcomes for patients.
Biosimilars: The biosimilars market is growing, and this is a cost-effective opportunity in the Crohn's disease treatment market. Pharmaceutical companies can take advantage of the patent expiration of biologics to develop biosimilars, thereby improving patient access to treatment and expanding the market in both developed and emerging regions.
Introduction of Oral Treatment Options: The shift toward oral treatments for Crohn's disease presents a strategic growth opportunity for pharmaceutical companies. With oral JAK inhibitors and other innovative treatments, companies can offer more convenient therapies that improve patient adherence, leading to increased market share and patient satisfaction.
Expanding into Emerging Markets: With the increasing prevalence of Crohn's disease in emerging markets like China and India, there is a significant opportunity to expand treatment access. Pharmaceutical companies can capitalize on this by introducing affordable therapies and leveraging local partnerships to improve the availability of Crohn's disease treatments.
Personalized Medicine and Genetic Testing: Personalized medicine offers an exciting growth opportunity by tailoring treatments based on genetic profiling. Pharmaceutical companies can invest in genetic testing platforms and companion diagnostics to optimize treatment regimens for Crohn's disease, providing more effective and individualized care.

Strategic growth opportunities in the Crohn's disease treatment drug market lie in biologics, biosimilars, oral therapies, expanding into emerging markets, and embracing personalized medicine. These opportunities provide companies with avenues to innovate, enhance patient care, and tap into new patient populations, driving growth in the market.

Crohn's Disease Treatment Drug Market Driver and Challenges

The Crohn's disease treatment drug market is influenced by various drivers and challenges, including advancements in medical technology, patient access, and regulatory dynamics. Understanding these factors is essential for stakeholders aiming to navigate the market's evolving landscape.

The factors responsible for driving the Crohn's disease treatment drug market include:

1. Technological Advancements in Biologic Therapies: Advances in biologic therapies, including monoclonal antibodies and anti-TNF agents, have significantly improved the treatment of Crohn's disease. These innovations allow for more targeted treatment, reducing inflammation and enhancing patient outcomes.

2. Increasing Awareness of Crohn's Disease: Growing awareness of Crohn's disease, both among patients and healthcare providers, is driving demand for new treatments. Early diagnosis and intervention are becoming more common, leading to improved patient care and greater use of advanced therapies.

3. Government and Healthcare Investments: Governments and healthcare organizations are increasingly investing in the treatment of chronic conditions like Crohn's disease. These investments support research and the availability of effective medications, helping to drive market growth and improve patient access to therapies.

4. Rising Prevalence of Crohn's Disease: The rising prevalence of Crohn's disease globally is increasing the demand for effective treatments. This trend is pushing pharmaceutical companies to develop new therapies and expand their portfolios to meet the needs of a growing patient population.

5. Regulatory Support for Drug Approvals: Favorable regulatory environments, especially in developed countries like the U.S. and Germany, are expediting the approval process for new Crohn's disease treatments. Faster approvals are allowing innovative therapies to reach the market sooner, benefiting patients in need.

Challenges in the Crohn's disease treatment drug market are:

1. High Treatment Costs: The high cost of biologics and advanced therapies remains a significant challenge, particularly for patients in low-income regions. The cost of these treatments can limit access to care and slow market growth.

2. Access to Treatment in Developing Regions: Limited access to treatment in developing regions, especially for advanced therapies like biologics, poses a challenge. This is due to both financial barriers and a lack of healthcare infrastructure.

3. Side Effects and Treatment Resistance: Some patients experience side effects from biologic therapies, and in some cases, they may develop resistance to these treatments. Managing these side effects and finding alternative therapies is an ongoing challenge.

The drivers, including technological advancements, increased awareness, and regulatory support, are fueling the growth of the Crohn's disease treatment drug market. However, challenges such as high costs, limited access to treatment, and side effects need to be addressed to fully optimize market potential.

List of Crohn's Disease Treatment Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, Crohn's disease treatment drug companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the Crohn's disease treatment drug companies profiled in this report include:

Biogen
UCB
Boehringer
AstraZeneca
AbbVie

Crohn's Disease Treatment Drug Market by Segment

The study includes a forecast for the global Crohn's disease treatment drug market by type, application, and region.

Crohn's Disease Treatment Drug Market by Type [Value from 2019 to 2031]:

Aminosalicylates
Corticosteroids
Immunomodulators
Antibiotics

Crohn's Disease Treatment Drug Market by Application [Value from 2019 to 2031]:

Small Intestine
Large Intestine

Crohn's Disease Treatment Drug Market by Region [Value from 2019 to 2031]:

North America
Europe
Asia Pacific
The Rest of the World

Country Wise Outlook for the Crohn's Disease Treatment Drug Market

The Crohn's Disease Treatment Drug market is dynamic with significant strides in medication and therapies to handle this chronic inflammatory bowel disease. As the cases of Crohn's disease grow worldwide, nations such as the United States, China, Germany, India, and Japan have made progress toward better treatment alternatives, which eventually led to successful patient outcomes and further growth of the market.

United States: The United States is the leader in Crohn's disease management, with continually increased application of biologic therapies like anti-TNF and anti-integrin antibodies. Novel drugs, including oral agents and Janus kinase (JAK) inhibitors, were recently approved to advance disease management. The emphasis will gradually shift towards personalized medicine that adapts the effectiveness of treatment according to genetic markers.
China: The market for treating Crohn's disease in China is growing in line with rising awareness and enhanced healthcare systems. Biologic treatments are becoming increasingly available, even though the costs are still quite high for many patients. Companies in the local pharmaceutical industry have been concentrating their efforts on manufacturing biosimilars, a move that should make biologics more accessible and increase patient access to a wider population of patients.
Germany: Germany has seen an increase in the adoption of biologic treatments and a focus on advanced therapies for Crohn's disease. The government's strong support for healthcare innovation and reimbursement policies ensures that patients have access to the latest therapies. There is also a growing emphasis on telemedicine and remote monitoring to improve patient adherence to treatments.
India: While in India, the Crohn's disease treatment market is obviously growing, access in certain areas is basically limited to leading-edge therapies. The awareness of Crohn's disease and its treatments is therefore increased, and above all, the government has been implementing policies in favor of improved access to healthcare. The private sector also is expanding the availability of biologics and immunosuppressive drugs.
Japan: Japan has been expanding its Crohn's disease treatment options, with increasing use of biologics like adalimumab and infliximab. In addition to biologics, Japan has introduced newer oral medications for inflammatory bowel diseases, offering more convenience for patients. The country is also emphasizing the development of precision medicine and the use of genetic testing to guide treatment choices.

Features of the Global Crohn's Disease Treatment Drug Market

Market Size Estimates: Crohn's disease treatment drug market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Crohn's disease treatment drug market size by type, application, and region in terms of value ($B).
Regional Analysis: Crohn's disease treatment drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the Crohn's disease treatment drug market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the Crohn's disease treatment drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the Crohn's disease treatment drug market by type (aminosalicylates, corticosteroids, immunomodulators, and antibiotics), application (small intestine and large intestine), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Market Overview

2.1 Background and Classifications
2.2 Supply Chain

3. Market Trends & Forecast Analysis

3.1 Macroeconomic Trends and Forecasts
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment

4. Global Crohn'S Disease Treatment Drug Market by Type

4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 Aminosalicylates: Trends and Forecast (2019-2031)
4.4 Corticosteroids: Trends and Forecast (2019-2031)
4.5 Immunomodulators: Trends and Forecast (2019-2031)
4.6 Antibiotics: Trends and Forecast (2019-2031)

5. Global Crohn'S Disease Treatment Drug Market by Application

5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 Small Intestine: Trends and Forecast (2019-2031)
5.4 Large Intestine: Trends and Forecast (2019-2031)

6. Regional Analysis

6.1 Overview
6.2 Global Crohn'S Disease Treatment Drug Market by Region

7. North American Crohn'S Disease Treatment Drug Market

7.1 Overview
7.2 North American Crohn'S Disease Treatment Drug Market by Type
7.3 North American Crohn'S Disease Treatment Drug Market by Application
7.4 United States Crohn'S Disease Treatment Drug Market
7.5 Mexican Crohn'S Disease Treatment Drug Market
7.6 Canadian Crohn'S Disease Treatment Drug Market

8. European Crohn'S Disease Treatment Drug Market

8.1 Overview
8.2 European Crohn'S Disease Treatment Drug Market by Type
8.3 European Crohn'S Disease Treatment Drug Market by Application
8.4 German Crohn'S Disease Treatment Drug Market
8.5 French Crohn'S Disease Treatment Drug Market
8.6 Spanish Crohn'S Disease Treatment Drug Market
8.7 Italian Crohn'S Disease Treatment Drug Market
8.8 United Kingdom Crohn'S Disease Treatment Drug Market

9. APAC Crohn'S Disease Treatment Drug Market

9.1 Overview
9.2 APAC Crohn'S Disease Treatment Drug Market by Type
9.3 APAC Crohn'S Disease Treatment Drug Market by Application
9.4 Japanese Crohn'S Disease Treatment Drug Market
9.5 Indian Crohn'S Disease Treatment Drug Market
9.6 Chinese Crohn'S Disease Treatment Drug Market
9.7 South Korean Crohn'S Disease Treatment Drug Market
9.8 Indonesian Crohn'S Disease Treatment Drug Market

10. ROW Crohn'S Disease Treatment Drug Market

10.1 Overview
10.2 ROW Crohn'S Disease Treatment Drug Market by Type
10.3 ROW Crohn'S Disease Treatment Drug Market by Application
10.4 Middle Eastern Crohn'S Disease Treatment Drug Market
10.5 South American Crohn'S Disease Treatment Drug Market
10.6 African Crohn'S Disease Treatment Drug Market

11. Competitor Analysis

11.1 Product Portfolio Analysis
11.2 Operational Integration
11.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

12.1 Value Chain Analysis
12.2 Growth Opportunity Analysis
- 12.2.1 Growth Opportunities by Type
- 12.2.2 Growth Opportunities by Application
12.3 Emerging Trends in the Global Crohn'S Disease Treatment Drug Market
12.4 Strategic Analysis
- 12.4.1 New Product Development
- 12.4.2 Certification and Licensing
- 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

13.1 Competitive Analysis
13.2 Biogen
- Company Overview
- Crohn'S Disease Treatment Drug Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.3 UCB
- Company Overview
- Crohn'S Disease Treatment Drug Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.4 Boehringer
- Company Overview
- Crohn'S Disease Treatment Drug Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.5 AstraZeneca
- Company Overview
- Crohn'S Disease Treatment Drug Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.6 AbbVie
- Company Overview
- Crohn'S Disease Treatment Drug Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing

14. Appendix

14.1 List of Figures
14.2 List of Tables
14.3 Research Methodology
14.4 Disclaimer
14.5 Copyright
14.6 Abbreviations and Technical Units
14.7 About Us
14.8 Contact Us

简介目录图表

List of Figures

Figure 1.1: Trends and Forecast for the Global Crohn'S Disease Treatment Drug Market
Figure 2.1: Usage of Crohn'S Disease Treatment Drug Market
Figure 2.2: Classification of the Global Crohn'S Disease Treatment Drug Market
Figure 2.3: Supply Chain of the Global Crohn'S Disease Treatment Drug Market
Figure 2.4: Driver and Challenges of the Crohn'S Disease Treatment Drug Market
Figure 3.1: Trends of the Global GDP Growth Rate
Figure 3.2: Trends of the Global Population Growth Rate
Figure 3.3: Trends of the Global Inflation Rate
Figure 3.4: Trends of the Global Unemployment Rate
Figure 3.5: Trends of the Regional GDP Growth Rate
Figure 3.6: Trends of the Regional Population Growth Rate
Figure 3.7: Trends of the Regional Inflation Rate
Figure 3.8: Trends of the Regional Unemployment Rate
Figure 3.9: Trends of Regional Per Capita Income
Figure 3.10: Forecast for the Global GDP Growth Rate
Figure 3.11: Forecast for the Global Population Growth Rate
Figure 3.12: Forecast for the Global Inflation Rate
Figure 3.13: Forecast for the Global Unemployment Rate
Figure 3.14: Forecast for the Regional GDP Growth Rate
Figure 3.15: Forecast for the Regional Population Growth Rate
Figure 3.16: Forecast for the Regional Inflation Rate
Figure 3.17: Forecast for the Regional Unemployment Rate
Figure 3.18: Forecast for Regional Per Capita Income
Figure 4.1: Global Crohn'S Disease Treatment Drug Market by Type in 2019, 2024, and 2031
Figure 4.2: Trends of the Global Crohn'S Disease Treatment Drug Market ($B) by Type
Figure 4.3: Forecast for the Global Crohn'S Disease Treatment Drug Market ($B) by Type
Figure 4.4: Trends and Forecast for Aminosalicylates in the Global Crohn'S Disease Treatment Drug Market (2019-2031)
Figure 4.5: Trends and Forecast for Corticosteroids in the Global Crohn'S Disease Treatment Drug Market (2019-2031)
Figure 4.6: Trends and Forecast for Immunomodulators in the Global Crohn'S Disease Treatment Drug Market (2019-2031)
Figure 4.7: Trends and Forecast for Antibiotics in the Global Crohn'S Disease Treatment Drug Market (2019-2031)
Figure 5.1: Global Crohn'S Disease Treatment Drug Market by Application in 2019, 2024, and 2031
Figure 5.2: Trends of the Global Crohn'S Disease Treatment Drug Market ($B) by Application
Figure 5.3: Forecast for the Global Crohn'S Disease Treatment Drug Market ($B) by Application
Figure 5.4: Trends and Forecast for Small Intestine in the Global Crohn'S Disease Treatment Drug Market (2019-2031)
Figure 5.5: Trends and Forecast for Large Intestine in the Global Crohn'S Disease Treatment Drug Market (2019-2031)
Figure 6.1: Trends of the Global Crohn'S Disease Treatment Drug Market ($B) by Region (2019-2024)
Figure 6.2: Forecast for the Global Crohn'S Disease Treatment Drug Market ($B) by Region (2025-2031)
Figure 7.1: Trends and Forecast for the North American Crohn'S Disease Treatment Drug Market (2019-2031)
Figure 7.2: North American Crohn'S Disease Treatment Drug Market by Type in 2019, 2024, and 2031
Figure 7.3: Trends of the North American Crohn'S Disease Treatment Drug Market ($B) by Type (2019-2024)
Figure 7.4: Forecast for the North American Crohn'S Disease Treatment Drug Market ($B) by Type (2025-2031)
Figure 7.5: North American Crohn'S Disease Treatment Drug Market by Application in 2019, 2024, and 2031
Figure 7.6: Trends of the North American Crohn'S Disease Treatment Drug Market ($B) by Application (2019-2024)
Figure 7.7: Forecast for the North American Crohn'S Disease Treatment Drug Market ($B) by Application (2025-2031)
Figure 7.8: Trends and Forecast for the United States Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
Figure 7.9: Trends and Forecast for the Mexican Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
Figure 7.10: Trends and Forecast for the Canadian Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
Figure 8.1: Trends and Forecast for the European Crohn'S Disease Treatment Drug Market (2019-2031)
Figure 8.2: European Crohn'S Disease Treatment Drug Market by Type in 2019, 2024, and 2031
Figure 8.3: Trends of the European Crohn'S Disease Treatment Drug Market ($B) by Type (2019-2024)
Figure 8.4: Forecast for the European Crohn'S Disease Treatment Drug Market ($B) by Type (2025-2031)
Figure 8.5: European Crohn'S Disease Treatment Drug Market by Application in 2019, 2024, and 2031
Figure 8.6: Trends of the European Crohn'S Disease Treatment Drug Market ($B) by Application (2019-2024)
Figure 8.7: Forecast for the European Crohn'S Disease Treatment Drug Market ($B) by Application (2025-2031)
Figure 8.8: Trends and Forecast for the German Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
Figure 8.9: Trends and Forecast for the French Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
Figure 8.10: Trends and Forecast for the Spanish Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
Figure 8.11: Trends and Forecast for the Italian Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
Figure 8.12: Trends and Forecast for the United Kingdom Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
Figure 9.1: Trends and Forecast for the APAC Crohn'S Disease Treatment Drug Market (2019-2031)
Figure 9.2: APAC Crohn'S Disease Treatment Drug Market by Type in 2019, 2024, and 2031
Figure 9.3: Trends of the APAC Crohn'S Disease Treatment Drug Market ($B) by Type (2019-2024)
Figure 9.4: Forecast for the APAC Crohn'S Disease Treatment Drug Market ($B) by Type (2025-2031)
Figure 9.5: APAC Crohn'S Disease Treatment Drug Market by Application in 2019, 2024, and 2031
Figure 9.6: Trends of the APAC Crohn'S Disease Treatment Drug Market ($B) by Application (2019-2024)
Figure 9.7: Forecast for the APAC Crohn'S Disease Treatment Drug Market ($B) by Application (2025-2031)
Figure 9.8: Trends and Forecast for the Japanese Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
Figure 9.9: Trends and Forecast for the Indian Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
Figure 9.10: Trends and Forecast for the Chinese Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
Figure 9.11: Trends and Forecast for the South Korean Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
Figure 9.12: Trends and Forecast for the Indonesian Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
Figure 10.1: Trends and Forecast for the ROW Crohn'S Disease Treatment Drug Market (2019-2031)
Figure 10.2: ROW Crohn'S Disease Treatment Drug Market by Type in 2019, 2024, and 2031
Figure 10.3: Trends of the ROW Crohn'S Disease Treatment Drug Market ($B) by Type (2019-2024)
Figure 10.4: Forecast for the ROW Crohn'S Disease Treatment Drug Market ($B) by Type (2025-2031)
Figure 10.5: ROW Crohn'S Disease Treatment Drug Market by Application in 2019, 2024, and 2031
Figure 10.6: Trends of the ROW Crohn'S Disease Treatment Drug Market ($B) by Application (2019-2024)
Figure 10.7: Forecast for the ROW Crohn'S Disease Treatment Drug Market ($B) by Application (2025-2031)
Figure 10.8: Trends and Forecast for the Middle Eastern Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
Figure 10.9: Trends and Forecast for the South American Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
Figure 10.10: Trends and Forecast for the African Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
Figure 11.1: Porter's Five Forces Analysis of the Global Crohn'S Disease Treatment Drug Market
Figure 11.2: Market Share (%) of Top Players in the Global Crohn'S Disease Treatment Drug Market (2024)
Figure 12.1: Growth Opportunities for the Global Crohn'S Disease Treatment Drug Market by Type
Figure 12.2: Growth Opportunities for the Global Crohn'S Disease Treatment Drug Market by Application
Figure 12.3: Growth Opportunities for the Global Crohn'S Disease Treatment Drug Market by Region
Figure 12.4: Emerging Trends in the Global Crohn'S Disease Treatment Drug Market

List of Tables

Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Crohn'S Disease Treatment Drug Market by Type and Application
Table 1.2: Attractiveness Analysis for the Crohn'S Disease Treatment Drug Market by Region
Table 1.3: Global Crohn'S Disease Treatment Drug Market Parameters and Attributes
Table 3.1: Trends of the Global Crohn'S Disease Treatment Drug Market (2019-2024)
Table 3.2: Forecast for the Global Crohn'S Disease Treatment Drug Market (2025-2031)
Table 4.1: Attractiveness Analysis for the Global Crohn'S Disease Treatment Drug Market by Type
Table 4.2: Market Size and CAGR of Various Type in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
Table 4.3: Market Size and CAGR of Various Type in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
Table 4.4: Trends of Aminosalicylates in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
Table 4.5: Forecast for Aminosalicylates in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
Table 4.6: Trends of Corticosteroids in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
Table 4.7: Forecast for Corticosteroids in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
Table 4.8: Trends of Immunomodulators in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
Table 4.9: Forecast for Immunomodulators in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
Table 4.10: Trends of Antibiotics in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
Table 4.11: Forecast for Antibiotics in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
Table 5.1: Attractiveness Analysis for the Global Crohn'S Disease Treatment Drug Market by Application
Table 5.2: Market Size and CAGR of Various Application in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
Table 5.3: Market Size and CAGR of Various Application in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
Table 5.4: Trends of Small Intestine in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
Table 5.5: Forecast for Small Intestine in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
Table 5.6: Trends of Large Intestine in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
Table 5.7: Forecast for Large Intestine in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
Table 6.1: Market Size and CAGR of Various Regions in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
Table 6.2: Market Size and CAGR of Various Regions in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
Table 7.1: Trends of the North American Crohn'S Disease Treatment Drug Market (2019-2024)
Table 7.2: Forecast for the North American Crohn'S Disease Treatment Drug Market (2025-2031)
Table 7.3: Market Size and CAGR of Various Type in the North American Crohn'S Disease Treatment Drug Market (2019-2024)
Table 7.4: Market Size and CAGR of Various Type in the North American Crohn'S Disease Treatment Drug Market (2025-2031)
Table 7.5: Market Size and CAGR of Various Application in the North American Crohn'S Disease Treatment Drug Market (2019-2024)
Table 7.6: Market Size and CAGR of Various Application in the North American Crohn'S Disease Treatment Drug Market (2025-2031)
Table 7.7: Trends and Forecast for the United States Crohn'S Disease Treatment Drug Market (2019-2031)
Table 7.8: Trends and Forecast for the Mexican Crohn'S Disease Treatment Drug Market (2019-2031)
Table 7.9: Trends and Forecast for the Canadian Crohn'S Disease Treatment Drug Market (2019-2031)
Table 8.1: Trends of the European Crohn'S Disease Treatment Drug Market (2019-2024)
Table 8.2: Forecast for the European Crohn'S Disease Treatment Drug Market (2025-2031)
Table 8.3: Market Size and CAGR of Various Type in the European Crohn'S Disease Treatment Drug Market (2019-2024)
Table 8.4: Market Size and CAGR of Various Type in the European Crohn'S Disease Treatment Drug Market (2025-2031)
Table 8.5: Market Size and CAGR of Various Application in the European Crohn'S Disease Treatment Drug Market (2019-2024)
Table 8.6: Market Size and CAGR of Various Application in the European Crohn'S Disease Treatment Drug Market (2025-2031)
Table 8.7: Trends and Forecast for the German Crohn'S Disease Treatment Drug Market (2019-2031)
Table 8.8: Trends and Forecast for the French Crohn'S Disease Treatment Drug Market (2019-2031)
Table 8.9: Trends and Forecast for the Spanish Crohn'S Disease Treatment Drug Market (2019-2031)
Table 8.10: Trends and Forecast for the Italian Crohn'S Disease Treatment Drug Market (2019-2031)
Table 8.11: Trends and Forecast for the United Kingdom Crohn'S Disease Treatment Drug Market (2019-2031)
Table 9.1: Trends of the APAC Crohn'S Disease Treatment Drug Market (2019-2024)
Table 9.2: Forecast for the APAC Crohn'S Disease Treatment Drug Market (2025-2031)
Table 9.3: Market Size and CAGR of Various Type in the APAC Crohn'S Disease Treatment Drug Market (2019-2024)
Table 9.4: Market Size and CAGR of Various Type in the APAC Crohn'S Disease Treatment Drug Market (2025-2031)
Table 9.5: Market Size and CAGR of Various Application in the APAC Crohn'S Disease Treatment Drug Market (2019-2024)
Table 9.6: Market Size and CAGR of Various Application in the APAC Crohn'S Disease Treatment Drug Market (2025-2031)
Table 9.7: Trends and Forecast for the Japanese Crohn'S Disease Treatment Drug Market (2019-2031)
Table 9.8: Trends and Forecast for the Indian Crohn'S Disease Treatment Drug Market (2019-2031)
Table 9.9: Trends and Forecast for the Chinese Crohn'S Disease Treatment Drug Market (2019-2031)
Table 9.10: Trends and Forecast for the South Korean Crohn'S Disease Treatment Drug Market (2019-2031)
Table 9.11: Trends and Forecast for the Indonesian Crohn'S Disease Treatment Drug Market (2019-2031)
Table 10.1: Trends of the ROW Crohn'S Disease Treatment Drug Market (2019-2024)
Table 10.2: Forecast for the ROW Crohn'S Disease Treatment Drug Market (2025-2031)
Table 10.3: Market Size and CAGR of Various Type in the ROW Crohn'S Disease Treatment Drug Market (2019-2024)
Table 10.4: Market Size and CAGR of Various Type in the ROW Crohn'S Disease Treatment Drug Market (2025-2031)
Table 10.5: Market Size and CAGR of Various Application in the ROW Crohn'S Disease Treatment Drug Market (2019-2024)
Table 10.6: Market Size and CAGR of Various Application in the ROW Crohn'S Disease Treatment Drug Market (2025-2031)
Table 10.7: Trends and Forecast for the Middle Eastern Crohn'S Disease Treatment Drug Market (2019-2031)
Table 10.8: Trends and Forecast for the South American Crohn'S Disease Treatment Drug Market (2019-2031)
Table 10.9: Trends and Forecast for the African Crohn'S Disease Treatment Drug Market (2019-2031)
Table 11.1: Product Mapping of Crohn'S Disease Treatment Drug Suppliers Based on Segments
Table 11.2: Operational Integration of Crohn'S Disease Treatment Drug Manufacturers
Table 11.3: Rankings of Suppliers Based on Crohn'S Disease Treatment Drug Revenue
Table 12.1: New Product Launches by Major Crohn'S Disease Treatment Drug Producers (2019-2024)
Table 12.2: Certification Acquired by Major Competitor in the Global Crohn'S Disease Treatment Drug Market

02-2729-4219

+886-2-2729-4219

License/价格

FAQ

全球克隆氏症药物市场报告：趋势、预测和竞争分析（至 2031 年）

Crohn's Disease Treatment Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

目录

第一章执行摘要

第二章 市场概述

第三章：市场趋势与预测分析

第四章克隆氏症药物市场（按类型）

第五章克隆氏症治疗药物市场（依应用）

第六章区域分析

7.北美克隆氏症药物市场

8.欧洲克隆氏症药物市场

9.亚太克克隆氏症药物市场

10. 世界其他地区克隆氏症症治疗市场

第十一章 竞争分析

第十二章机会与策略分析

第十三章：价值链主要企业概况

第十四章 附录